Mycoplasma Testing Market Forecast Highlighting Industry Trends and Progress

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Is The Estimated Market Size Of The Mycoplasma Testing Market In 2026, And How Will Its Value Evolve By 2030?

The mycoplasma testing market has seen rapid expansion in recent years. Its valuation is expected to climb from $1.23 billion in 2025 to $1.38 billion in 2026, reflecting a compound annual growth rate (CAGR) of 12.1%. This historical growth can be linked to the high prevalence of mycoplasma contamination, a greater reliance on cell culture testing, an increased demand for diagnostic testing, the early adoption of PCR methods, and the rising utilization of ELISA techniques.

The mycoplasma testing market size is poised for substantial expansion over the next few years. It is projected to achieve a value of $2.1 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 11.1%. This anticipated growth during the forecast period is influenced by several factors, including the expansion of biopharmaceutical manufacturing, an increase in CRO outsourcing, greater investment in genomic testing, a heightened regulatory focus on contamination control, and the adoption of automated testing platforms. Significant trends for the forecast period comprise the increasing uptake of pcr-based mycoplasma detection, a rise in the use of rapid test kits for cell culture screening, growing demand for automated mycoplasma detection systems, the wider application of assay and reagent usage in biopharmaceutical production, and an elevated need for mycoplasma testing in research and cro settings.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=4103&type=smp

What Factors Are Contributing To The Growth Of The Mycoplasma Testing Market?

The rising incidence of mycoplasma pneumonia is projected to drive the expansion of the mycoplasma testing market moving forward. Mycoplasma pneumonia is a respiratory infection caused by the bacterium Mycoplasma pneumoniae. Mycoplasma testing is essential for diagnosing Mycoplasma pneumonia by identifying the presence of Mycoplasma pneumoniae bacteria in respiratory samples, thereby facilitating the prompt and accurate detection of the infection for proper medical management and treatment. For instance, in December 2023, the Centers for Disease Control and Prevention, a US-based government agency, estimated that approximately 2 million cases of Mycoplasma pneumoniae infections occur each year in the United States. Therefore, the increasing prevalence of mycoplasma pneumonia is fueling the growth of the mycoplasma testing market.

How Are Different Segments Classified In The Mycoplasma Testing Market Segment Analysis?

The mycoplasma testing market covered in this report is segmented –

1) By Product: Instruments, Assay, Kits, Reagents

2) By Technology: PCR, Elisa, Enzymatic Methods, DNA Staining, Other Technologies

3) By Application: Cell Line Testing, Virus Testing, End- Of- Production Cell Testing

4) By End User: Pharmaceutical & Biotechnology Companies, Cell Banks And Laboratories, Contract Research Organizations, Academic Research Institutes

Subsegments:

1) By Instruments: Mycoplasma Detection Systems, Automated Test Equipment, PCR Equipment

2) By Assay: Mycoplasma Assays, Qualitative Assays, Quantitative Assays

3) By Kits: Mycoplasma Detection Kits, Mycoplasma Testing Kits For Cell Cultures, Sample Preparation Kits

4) By Reagents: Nucleic Acid Reagents, Cell Culture Reagents, Staining Reagents

What Trends Are Shaping The Future Of The Mycoplasma Testing Market?

Major entities operating within the mycoplasma testing market are increasingly concentrating on introducing digital PCR kits to secure a competitive advantage. These digital PCR kits represent molecular biology instruments that facilitate the exact quantification and examination of nucleic acids, such as DNA or RNA, through a digital methodology. For instance, in November 2023, QIAGEN, a diagnostics company based in Germany, released three new QIAcuity digital PCR kits along with enhanced software, aiming to broaden the utility of digital PCR applications in biopharmaceutical investigations and food safety. The recently introduced QIAcuity kits are engineered for accurate quantification and come in configurations of one, four, and eight plates, with the single-plate model capable of processing as many as 384 samples within an eight-hour shift. Among the new kits launched is the QIAcuity Mycoplasma Quant Kit, which provides researchers with a reliable and precise method for identifying mycoplasma contaminants at every stage of research.

Who Are The Companies Driving Activity In The Mycoplasma Testing Market?

Major companies operating in the mycoplasma testing market are Merck KGaA, Thermo Fisher Scientific Inc., Agilent Technologies Inc., Lonza Group AG, Roche Diagnostics International AG, Charles River Laboratories International Inc., Nelson Laboratories Fairfield Inc., Creative Bioarray, Biological Industries Israel Beit Haemek Ltd., Biotools B & M Labs S.A, PromoCell GmbH, American Type Culture Collection, Bionique Testing Laboratories Inc., InvivoGen, Clongen Laboratories LLC, Norgen Biotek Corporation, Gen Bio Sciences (P) Ltd., GeneCopoeia Inc., Minerva Biolabs GmbH, Mycoplasma Experience, Savyon Diagnostics, ScienCell Research Laboratories Inc.

Get The Full Mycoplasma Testing Market Report:

https://www.thebusinessresearchcompany.com/report/mycoplasma-testing-global-market-report

Which Region Is The Largest In The Mycoplasma Testing Market?

North America was the largest region in the mycoplasma testing market in 2025. Asia-Pacific is expected to be the fastest growing region in the forecast period. The regions covered in the mycoplasma testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Mycoplasma Testing Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/mycoplasma-testing-global-market-report

Browse Through More Reports Similar to the Global Mycoplasma Testing Market 2026, By The Business Research Company

Tuberculosis Diagnostics Market Report 2026

https://www.thebusinessresearchcompany.com/report/tuberculosis-diagnostics-global-market-report

Bactericide Market Report

https://www.thebusinessresearchcompany.com/report/bactericide-global-market-report

Amoxicillin Market Report

https://www.thebusinessresearchcompany.com/report/amoxicillin-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795